What biomaterials and material technologies does Evergen offer?

Updated

Evergen (evergenbio.com) supplies allograft and xenograft biomaterials to Original Equipment Manufacturers (OEMs), together with the material and process technologies needed to turn those biomaterials into finished regenerative medicine products. The company describes itself as a global Contract Development and Manufacturing Organization (CDMO) that designs, develops, and manufactures customized regenerative biomaterial solutions. If you are an OEM or device developer looking for a manufacturing partner rather than an off-the-shelf catalog product, this is the relevant part of Evergen's offering.

What Evergen actually provides

Evergen's biomaterials business is built around two things: the raw biomaterial itself and the technical capabilities to process it.

  • Allograft biomaterials — tissue-derived materials sourced through donor services.
  • Xenograft biomaterials — animal-derived biomaterials.
  • Customized services — Evergen states it provides tailored services to meet OEM requirements rather than standardized products.
  • Material technologies and process technologies — two capability categories listed on the site, covering how biomaterials are formulated and how they are manufactured.

The stated purpose of these biomaterials is to support the body's natural healing process, with the goal of promoting healing, accelerating recovery, and helping prevent complications.

How the technologies are organized

Evergen splits its technical offering into two labeled areas:

Category What it covers (per site)
Material Technologies The biomaterial composition and properties used in regenerative applications
Process Technologies The manufacturing and processing methods applied to those materials

The site links both categories under its Biomaterials section but does not publish detailed specifications, material grades, or a product list on the homepage. For specifics, an OEM would need to engage Evergen directly through its contact or services channels.

Clinical areas of expertise

Evergen states deep clinical expertise in the following areas, which is where its biomaterials are intended to be applied:

  • Plastic and reconstructive surgery
  • Sports medicine and orthopedics
  • Neuro/spine
  • Cardiac

This matters if your device or therapy falls into one of these categories — it suggests the company already has relevant development and manufacturing experience rather than treating your application as new territory.

Scale and track record

For an OEM evaluating a CDMO partner, Evergen cites the following milestones since its founding in 1998:

  • 20M+ implants enhancing patients' lives worldwide
  • 200+ market authorizations
  • 50+ 510(k) clearances

These figures indicate regulatory and commercial experience across multiple markets, which is typically a key screening criterion when selecting a biomaterials manufacturing partner.

Who this is for

Evergen's model is partnership-based, not direct-to-consumer. The company works with OEMs to design, develop, and manufacture customized solutions. If you need:

  • A co-development partner for a regenerative biomaterial component, or
  • A contract manufacturer with allograft/xenograft sourcing and processing capability,

then Evergen's services and biomaterials pages are the right starting points. If you are looking for a published catalog with pricing and part numbers, the site does not present one — engagement appears to begin with a direct partnership conversation.